These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 32308772)

  • 41. Coumarins modulate the anti-glioma properties of temozolomide.
    Sumorek-Wiadro J; Zając A; Bądziul D; Langner E; Skalicka-Woźniak K; Maciejczyk A; Wertel I; Rzeski W; Jakubowicz-Gil J
    Eur J Pharmacol; 2020 Aug; 881():173207. PubMed ID: 32446712
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reactive species balance via GTP cyclohydrolase I regulates glioblastoma growth and tumor initiating cell maintenance.
    Tran AN; Walker K; Harrison DG; Chen W; Mobley J; Hocevar L; Hackney JR; Sedaka RS; Pollock JS; Goldberg MS; Hambardzumyan D; Cooper SJ; Gillespie Y; Hjelmeland AB
    Neuro Oncol; 2018 Jul; 20(8):1055-1067. PubMed ID: 29409010
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chloroquine, an autophagy inhibitor, potentiates the radiosensitivity of glioma initiating cells by inhibiting autophagy and activating apoptosis.
    Ye H; Chen M; Cao F; Huang H; Zhan R; Zheng X
    BMC Neurol; 2016 Sep; 16(1):178. PubMed ID: 27644442
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Resveratrol promotes proteasome-dependent degradation of Nanog via p53 activation and induces differentiation of glioma stem cells.
    Sato A; Okada M; Shibuya K; Watanabe E; Seino S; Suzuki K; Narita Y; Shibui S; Kayama T; Kitanaka C
    Stem Cell Res; 2013 Jul; 11(1):601-10. PubMed ID: 23651583
    [TBL] [Abstract][Full Text] [Related]  

  • 45. FOXD1-ALDH1A3 Signaling Is a Determinant for the Self-Renewal and Tumorigenicity of Mesenchymal Glioma Stem Cells.
    Cheng P; Wang J; Waghmare I; Sartini S; Coviello V; Zhang Z; Kim SH; Mohyeldin A; Pavlyukov MS; Minata M; Valentim CL; Chhipa RR; Bhat KP; Dasgupta B; La Motta C; Kango-Singh M; Nakano I
    Cancer Res; 2016 Dec; 76(24):7219-7230. PubMed ID: 27569208
    [TBL] [Abstract][Full Text] [Related]  

  • 46. β-catenin contributes to cordycepin-induced MGMT inhibition and reduction of temozolomide resistance in glioma cells by increasing intracellular reactive oxygen species.
    Bi Y; Li H; Yi D; Bai Y; Zhong S; Liu Q; Chen Y; Zhao G
    Cancer Lett; 2018 Oct; 435():66-79. PubMed ID: 30081068
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HMGA2 sustains self-renewal and invasiveness of glioma-initiating cells.
    Zhong X; Liu X; Li Y; Cheng M; Wang W; Tian K; Mu L; Zeng T; Liu Y; Jiang X; Yu L; Gao L; Zhou Y
    Oncotarget; 2016 Jul; 7(28):44365-44380. PubMed ID: 27259253
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Autocrine TGF-beta signaling maintains tumorigenicity of glioma-initiating cells through Sry-related HMG-box factors.
    Ikushima H; Todo T; Ino Y; Takahashi M; Miyazawa K; Miyazono K
    Cell Stem Cell; 2009 Nov; 5(5):504-14. PubMed ID: 19896441
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nicardipine sensitizes temozolomide by inhibiting autophagy and promoting cell apoptosis in glioma stem cells.
    Shi J; Dong X; Li H; Wang H; Jiang Q; Liu L; Wang L; Dong J
    Aging (Albany NY); 2021 Feb; 13(5):6820-6831. PubMed ID: 33621205
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MIR93 (microRNA -93) regulates tumorigenicity and therapy response of glioblastoma by targeting autophagy.
    Huang T; Wan X; Alvarez AA; James CD; Song X; Yang Y; Sastry N; Nakano I; Sulman EP; Hu B; Cheng SY
    Autophagy; 2019 Jun; 15(6):1100-1111. PubMed ID: 30654687
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 20(S)-ginsenoside-Rg3 reverses temozolomide resistance and restrains epithelial-mesenchymal transition progression in glioblastoma.
    Chen Z; Wei X; Shen L; Zhu H; Zheng X
    Cancer Sci; 2019 Jan; 110(1):389-400. PubMed ID: 30431207
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Glioma initiating cells form a differentiation niche via the induction of extracellular matrices and integrin αV.
    Niibori-Nambu A; Midorikawa U; Mizuguchi S; Hide T; Nagai M; Komohara Y; Nagayama M; Hirayama M; Kobayashi D; Tsubota N; Takezaki T; Makino K; Nakamura H; Takeya M; Kuratsu J; Araki N
    PLoS One; 2013; 8(5):e59558. PubMed ID: 23704872
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dedifferentiation of Glioma Cells to Glioma Stem-like Cells By Therapeutic Stress-induced HIF Signaling in the Recurrent GBM Model.
    Lee G; Auffinger B; Guo D; Hasan T; Deheeger M; Tobias AL; Kim JY; Atashi F; Zhang L; Lesniak MS; James CD; Ahmed AU
    Mol Cancer Ther; 2016 Dec; 15(12):3064-3076. PubMed ID: 27765847
    [TBL] [Abstract][Full Text] [Related]  

  • 54. T-Type Ca
    Visa A; Sallán MC; Maiques O; Alza L; Talavera E; López-Ortega R; Santacana M; Herreros J; Cantí C
    Cancer Res; 2019 Apr; 79(8):1857-1868. PubMed ID: 30755443
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Targeting PBK/TOPK decreases growth and survival of glioma initiating cells in vitro and attenuates tumor growth in vivo.
    Joel M; Mughal AA; Grieg Z; Murrell W; Palmero S; Mikkelsen B; Fjerdingstad HB; Sandberg CJ; Behnan J; Glover JC; Langmoen IA; Stangeland B
    Mol Cancer; 2015 Jun; 14():121. PubMed ID: 26081429
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Snail depletes the tumorigenic potential of glioblastoma.
    Savary K; Caglayan D; Caja L; Tzavlaki K; Bin Nayeem S; Bergström T; Jiang Y; Uhrbom L; Forsberg-Nilsson K; Westermark B; Heldin CH; Ferletta M; Moustakas A
    Oncogene; 2013 Nov; 32(47):5409-20. PubMed ID: 23524585
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nimotuzumab enhances temozolomide-induced growth suppression of glioma cells expressing mutant EGFR in vivo.
    Nitta Y; Shimizu S; Shishido-Hara Y; Suzuki K; Shiokawa Y; Nagane M
    Cancer Med; 2016 Mar; 5(3):486-99. PubMed ID: 26778701
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Blockade of crizotinib-induced BCL2 elevation in ALK-positive anaplastic large cell lymphoma triggers autophagy associated with cell death.
    Torossian A; Broin N; Frentzel J; Daugrois C; Gandarillas S; Saati TA; Lamant L; Brousset P; Giuriato S; Espinos E
    Haematologica; 2019 Jul; 104(7):1428-1439. PubMed ID: 30679328
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cellular plasticity confers migratory and invasive advantages to a population of glioblastoma-initiating cells that infiltrate peritumoral tissue.
    Ruiz-Ontañon P; Orgaz JL; Aldaz B; Elosegui-Artola A; Martino J; Berciano MT; Montero JA; Grande L; Nogueira L; Diaz-Moralli S; Esparís-Ogando A; Vazquez-Barquero A; Lafarga M; Pandiella A; Cascante M; Segura V; Martinez-Climent JA; Sanz-Moreno V; Fernandez-Luna JL
    Stem Cells; 2013 Jun; 31(6):1075-85. PubMed ID: 23401361
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of a side population of astrocytoma cells in response to temozolomide.
    Chua C; Zaiden N; Chong KH; See SJ; Wong MC; Ang BT; Tang C
    J Neurosurg; 2008 Nov; 109(5):856-66. PubMed ID: 18976075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.